[HTML][HTML] Next-generation treatments: Immunotherapy and advanced therapies for COVID-19

JA Arevalo-Romero, SM Chingaté-López, BA Camacho… - Heliyon, 2024 - cell.com
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), emerged in 2019 following prior outbreaks of coronaviruses like SARS and …

Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients

E Duijvelaar, J Gisby, JE Peters, HJ Bogaard… - Nature …, 2024 - nature.com
The pathobiology of respiratory failure in COVID-19 consists of a complex interplay between
viral cytopathic effects and a dysregulated host immune response. In critically ill patients …

[HTML][HTML] Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection

JA Shaw, ST Malherbe, G Walzl… - Frontiers in …, 2023 - frontiersin.org
Epidemiologic data show that both current and previous tuberculosis (TB) increase the risk
of in-hospital mortality from coronavirus disease-2019 (COVID-19), and there is a similar …

Identification of key genes as potential diagnostic and therapeutic targets for comorbidity of myasthenia gravis and COVID-19

L Huang, Y Zuo, H Yang, X He, L Zhang - Frontiers in Neurology, 2024 - frontiersin.org
Introduction Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder.
Coronavirus disease 2019 (COVID-19) has a significant impact on the health and quality of …

[HTML][HTML] Identification of key genes as potential diagnostic and therapeutic targets for comorbidity of myasthenia gravis and COVID-19

L Huang, Y Zuo, H Yang, X He, L Zhang - Frontiers in Neurology, 2024 - frontiersin.org
Introduction Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder.
Coronavirus disease 2019 (COVID-19) has a significant impact on the health and quality of …

[HTML][HTML] Implications of empirical administration of caspofungin in COVID-19 complicated fungal infections

K Itoh, H Tsutani, Y Mitsuke, H Iwasaki - Frontiers in Cellular and …, 2023 - frontiersin.org
Candida and Aspergillus spp. were identified as the most common causes of invasive fungal
infections in COVID-19 patients (Ezeokoli et al., 2020). The mortality rate of invasive …

Longitudinal plasma proteomics reveals alveolar-capillary barrier disruption in critically ill COVID-19 patients

E Duijvelaar, J Gisby, J Peters, HJ Bogaard, J Aman - 2023 - researchsquare.com
The pathobiology of respiratory failure in COVID-19 consists of a complex interplay between
direct viral cytopathic effects and a dysregulated host immune response. In a randomised …